Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links
Cat.#: ACPP-1494
| Despition | beta Catenin Blocking Peptide |
| SIZE | 250 µg |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1197 | Dopamine Transporter Blocking Peptide (AC1197) | 250 µg | inquiry |
| ACPP-1221 | Bestrophin Blocking Peptide (AC1221) | 250 µg | inquiry |
| ACPP-1458 | Mouse LGALS3 Protein (AC1458) | 2 µg | inquiry |
| ACPP-1268 | Human LGALS3 Protein (AC1268) | 10 µg | inquiry |
| ACPP-1493 | Human Thyroid Stimulating Hormone Receptor (Active) Protein (AC1493) | 1 mg | inquiry |
| ACPP-1835 | Human RP9 Protein (AC1835) | 5 µg | inquiry |
| ACPP-1775 | Human SNPH Protein (AC1775) | 10 µg | inquiry |
| ACPP-1721 | Human QPRT Protein (AC1721) | 5 µg | inquiry |
| ACPP-1287 | Dopamine Receptor D1 Blocking Peptide (AC1287) | 250 µg | inquiry |
| ACPP-1343 | GIRK1 Blocking Peptide (AC1343) | 250 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.